Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer

American Journal of Pathology

Volumn 175, Issue 3, 2009, Pages 976-987

  Yazawa, Takuya ^a   Sato, Hanako ^a,b   Shimoyamada, Hiroaki ^a   Okudela, Koji ^a   Woo, Tetsukan ^a,c   Tajiri, Michihiko ^c   Ogura, Takashi ^c   Ogawa, Nobuo ^c   Suzuki, Takehisa ^a   Mitsui, Hideaki ^a   Ishii, Jun ^a   Miyata, Chie ^a   Sakaeda, Masashi ^a   Goto, Kazuya ^a   Kashiwagi, Korehito ^a   Masuda, Munetaka ^a   Takahashi, Takashi ^d   Kitamura, Hitoshi ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kanagawa Prefectural Cardiovascular and Respiratory Diseases Center Hospital   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROGENIC DIFFERENTIATION FACTOR; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 2; TRANSCRIPTION FACTOR;

5' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL GROWTH; CELL SPECIFICITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; E BOX ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; NEUROSECRETORY CELL; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; RECEPTOR UPREGULATION;

EID: 70349232342     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081004     Document Type: Article

References (48)

1. Travis WB, Nicholson S, Hirsch FR, Pugatch B, Geisinger K, Brambilla E, Gazdar A, Petersen I, Meyerson M, Hanash SM, Jen J, Takahashi T, Fernandez EA, Capron F: Small cell carcinoma. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Edited by Travis WB, Brambilla E, Muller-Hermelink HK, Harris CC. Lyon, IARC Press, 2004, pp 31-34
2. Colby TV, Koss MN, Travis WD: Small cell carcinoma and large cell neuroendocrine carcinoma. Atlas of Tumor Pathology. Tumors of the Lower Respiratory Tract. Edited by Rosai J. Washington DC, Armed Forced Institute of Pathology, 1995, pp 235-257
3. Nakanishi Y, Mulshine JL, Kasprzyk PG, Natale RB, Maneckjee R, Avis I, Treston AM, Gazdar AF, Minna JD, Cuttitta F: Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 1988, 82:354-359 (Pubitemid 18262538)
4. Macaulay VM, Everard MJ, Teale JD, Trott PA, Van Wyk JJ, Smith IE, Millar JL: Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res 1990, 50:2511-2517
5. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD: Bonbesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985, 316:823-826 (Pubitemid 15003742)
6. Reeve JG, Brinkman A, Hughes S, Mitchell J, Schwander J, Bleehen NM: Expression of insulin-like growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines. J Natl Cancer Institute 1992, 84:628-634
7. Jaques G, Kiefer P, Rotsch M, Hennig C, Goke R, Richter G, Havemann K: Production of insulin-like growth factor binding proteins by small-cell lung cancer cell lines. Exp Cell Res 1989, 184:396-406 (Pubitemid 19259723)
8. Reeve JG, Morgan AJ, Schwander J, Bleehen NM: Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Cancer Res 1993, 53:4680-4685 (Pubitemid 23304400)
9. Hwa V, Oh Y, Rosenfeld RG: The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999, 20:761-787 (Pubitemid 30648894)
10. Firth SM, Baxter RC: Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002, 23:824-1584
11. Sato H, Yazawa T, Suzuki T, Shimoyamada H, Okudela K, Ikeda M, Hamada K, Yamada-Okabe H, Yao M, Kubota Y, Takahashi T, Kamma H, Kitamura H: Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia. Am J Pathol 2006, 169:1550-1566 (Pubitemid 351181988)
12. Ball DW, Azzoli CG, Baylin SB, Chi D, Dou S, Donis-Keller H, Cumaraswamy A, Borges M, Nelkin BD: Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci USA 1993, 90:5648-15562 (Pubitemid 23176218)
13. Borges M, Linnoila RI, van de Verlde HJK, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW: An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 1997, 386:852-855 (Pubitemid 27181261)
14. Hiroshima K, Iyoda A, Shida T, Shibuya K, Iizasa T, Kishi H, Tanizawa T, Fujisawa T, Nakatani Y: Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Pathol 2006, 19:1358-1368 (Pubitemid 44423084)
15. Westerman BA, Breuer RH, Poutsma A, Chhatta A, Noorduyn LA, Koolen MG, Postmus PE, Blankenstein MA, Oudejans CB: Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors. Int J Biol Markers 2007, 22:114-123 (Pubitemid 47062216)
16. Bertrand N, Castro DS, Guillemot F: Proneural genes and the specification of neural cell types. Nature Rev Neurosci 2002, 3:517-530 (Pubitemid 135706662)
17. Chu K, Nemoz-Gaillard E, Tsai MJ: BETA2 and pancreatic islet development. Recent Prog Horm Res 2001, 56:23-46
18. Morrow EM, Furukawa T, Lee JE, Cepko CL: NeuroD regulates multiple functions in the developing neural retina in rodent. Development 1999, 126:23-36 (Pubitemid 29045897)
19. Miyata T, Maeda T, Lee JE: NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev 1999, 13:1647-1652 (Pubitemid 29325870)
20. Kim WY, Fritzsch B, Serls A, Bakel LA, Huang EJ, Reichardt LF, Barth DS, Lee JE: NeuroD-null mice are deaf due to a severe loss of the inner ear sensory neurons during development. Development 2001, 128:417-426 (Pubitemid 32184382)
21. Mutoh H, Fung BP, Naya FJ, Tsai MJ, Nishitani J, Leiter AB: The basic helix-loop-helix transcription factor BETA2/NeuroD is expressed in mammalian enteroendocrine cells and activates secretin gene expression. Proc Natl Acad Sci USA 1997, 94:3560-3564 (Pubitemid 27180411)
22. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ: Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 1997, 11:2323-2334 (Pubitemid 27408530)
23. Johnson JE, Birren SJ, Anderson DJ: Two rat homologues of Drosophila achaete-scute specifically expressed in neuronal precursors. Nature (London) 1990, 346:858-861 (Pubitemid 20272108)
24. Lee JE, Hollenberg SM, Snider L, Turner DL, Lipnick N, Weintraub H: Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 1995, 268:836-844
25. Kageyama R, Nakanishi S: Helix-loop-helix factors in growth and differentiation of the vertebrate nervous system. Curr Opin Genet Dev 1997, 7:659-665 (Pubitemid 27491431)
26. Ito T, Udaka N, Yazawa T, Okudela K, Hayashi H, Sudo T, Guillemot F, Kageyama R, Kitamura H: Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development 2000, 127:3913-3921 (Pubitemid 30793770)
27. Naptune ER, Podowski M, Calvi C, Cho JH, Tuder R, Linnoila RI, Tsai MJ, Dietz HC: Role of NeuroD in airway and airspace morphogenesis. J Biol Chem 2008, 283:21160-21169
28. Yazawa T, Ito T, Kamma H, Suzuki T, Okudela K, Hayashi H, Horiguchi H, Ogata T, Mutsui H, Ikeda M, Kitamura H: Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma. Am J Pathol 2002, 161:291-300 (Pubitemid 34760795)
29. Yazawa T, Kamma H, Fujiwara M, Matsui M, Horiguchi H, Satoh H, Fujimoto M, Yokoyama K, Ogata T: Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer. J Pathol 1999, 187:191-199 (Pubitemid 29037048)
30. Stahel RA, Ginsberg R, Havemann K, Hirsch FR, Ihde DC, Jassem J, Karrer K, Maurer LH, Osterlind K, Houtte PV: Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989, 5:119-126 (Pubitemid 20053516)
31. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 1997, 111:1710-1717 (Pubitemid 27260107)
32. Naya FJ, Stellrecht CM, Tsai MJ: Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 1995, 9:1009-10019
33. Menouny M, Binoux M, Babajko S: Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: modulation by transforming growth factor-b and retinoic acid. Endocrinol 1997, 138:683-690 (Pubitemid 27110919)
34. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP, Kononen J: Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000, 60:6617-6622
35. Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WKA, Zhang W: Reactivation of insulin-like growth factor binding protein-2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res 1999, 59:4228-4232 (Pubitemid 29418733)
36. Cindolo L, Franco R, Cantile M, Schavo G, Liguori G, Chiodini P, Salzano L, Autorino R, Di Blasi A, Falsaperla M, Feudale E, Botti G, Gallo A, Cillo C: NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension? Eur Urol 2007, 52:1365-1373
37. Ho P, Baxter RC: Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol 1997, 46:333-342 (Pubitemid 27174339)
38. Baron-Hey S, Boyle F, Ferrier A, Scott C: Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin Cancer Res 2004, 10:1796-1806 (Pubitemid 38435571)
39. El Atiq F, Garrouste F, Remacle-Bonnet M, Sastre B, Pommier G: Alterations in serum levels of insulin-like growth factors and insulin-like growth factor binding proteins in patients with colorectal cancer. Int J Cancer 1994, 57:491-497 (Pubitemid 24173092)
40. Rostomily RC, Bermingham-McDonogh O, Berger MS, Tapscott SJ, Reh TA, Olson JM: Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res 1997, 57:3526-3531 (Pubitemid 27355503)
41. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD: Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 1985, 45:2913-2923 (Pubitemid 15232769)
42. Gazdar AF, Carney DN, Nau MM, Minna JD: Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res 1985, 45:2924-2930
43. Wistuba II, Gazdar AF, Minna JD. Molecular genetics of small cell lung carcinoma. Semin Oncol 2001, 28(2 Suppl 4):3-13 (Pubitemid 32730372)
44. Russo VC, Schutt BS, Andaloro E, Ymer SI, Hoeflich A, Ranke MB, Bach LA, Werther GA: Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. Endocrinol 2005, 146:4445-4455 (Pubitemid 41324043)
45. Fukushima T, Tezuka T, Shimomura T, Nakano S, Kataoka H: Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J Biol Chem 2007, 282:18634-18644 (Pubitemid 47100243)
46. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, Haslett C: Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999, 6:662-668 (Pubitemid 29289430)
47. Westerman BA, Neijenhuis S, Poutsma A, Steenbergen RDM, Breuer RHJ, Egging M, van Wijk IJ, Oudejans CBM: Quantitative reverse transcription- polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. Clin Cancer Res 2002, 8:1082-1086 (Pubitemid 35177359)
48. Osada H, Tomida S, Yatabe Y, Tatematsu Y, Takeuchi T, Murakami H, Kondo Y, Sekido Y, Takahashi T: Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res 2008, 68:1647-1655